Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA for Neurocognitive Impairment in HIV Patients
NCT04242004Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Oct 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docosahexaenoic acid in neurocognitive disorder (NCD), sponsored by Fudan University. Status: unknown.
02
Drugs
docosahexaenoic acid
03
Conditions
neurocognitive disorder (NCD)
Beyond the preview
Go deeper on NCT04242004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04242004.